RATIONALE: Rapid tryptophan depletion (RTD) has been used to study central serotonin function and may therefore be useful in understanding co-morbid alcohol dependence (AD) and major depressive disorder (MDD). OBJECTIVES: To examine (1) the effect of RTD on mood and urge to drink among patients with AD and MDD and (2) the association of RTD effects with alleles of a functional polymorphism in the gene encoding the serotonin transporter protein. METHODS: Double-blind, placebo-controlled study, in which 14 treatment responders recruited from one of two placebo-controlled trials of serotonergic antidepressants were enrolled. Patients underwent two day-long sessions, which were either a tryptophan depletion session or a sham session. During each session, mood and urge for alcohol were measured at regular intervals. RESULTS: Five hours after RTD, plasma TRP concentrations decreased by 73.1%. There was a significant effect of session on both mood and the urge to drink. Genotype moderated the effect of session on mood, such that, during RTD, individuals homozygous for the long allele reported greater depression than did subjects with one or two copies of the S allele. CONCLUSIONS: This study provides support for the role of serotonergic neurotransmission in modulating mood and alcohol urges, and underscores the utility of these effects as a phenotype for genetic analysis. These findings may also help to identify alcoholics who are at greatest risk for MDD.
RCT Entities:
RATIONALE: Rapid tryptophan depletion (RTD) has been used to study central serotonin function and may therefore be useful in understanding co-morbid alcohol dependence (AD) and major depressive disorder (MDD). OBJECTIVES: To examine (1) the effect of RTD on mood and urge to drink among patients with AD and MDD and (2) the association of RTD effects with alleles of a functional polymorphism in the gene encoding the serotonin transporter protein. METHODS: Double-blind, placebo-controlled study, in which 14 treatment responders recruited from one of two placebo-controlled trials of serotonergic antidepressants were enrolled. Patients underwent two day-long sessions, which were either a tryptophan depletion session or a sham session. During each session, mood and urge for alcohol were measured at regular intervals. RESULTS: Five hours after RTD, plasma TRP concentrations decreased by 73.1%. There was a significant effect of session on both mood and the urge to drink. Genotype moderated the effect of session on mood, such that, during RTD, individuals homozygous for the long allele reported greater depression than did subjects with one or two copies of the S allele. CONCLUSIONS: This study provides support for the role of serotonergic neurotransmission in modulating mood and alcohol urges, and underscores the utility of these effects as a phenotype for genetic analysis. These findings may also help to identify alcoholics who are at greatest risk for MDD.
Authors: J D Bremner; R B Innis; R M Salomon; L H Staib; C K Ng; H L Miller; R A Bronen; J H Krystal; J Duncan; D Rich; L H Price; R Malison; H Dey; R Soufer; D S Charney Journal: Arch Gen Psychiatry Date: 1997-04
Authors: M K Spillmann; A J Van der Does; M A Rankin; R D Vuolo; J E Alpert; A A Nierenberg; J F Rosenbaum; D Hayden; D Schoenfeld; M Fava Journal: Psychopharmacology (Berl) Date: 2001-05 Impact factor: 4.530
Authors: S A Montgomery; P Bebbington; P Cowen; W Deakin; P Freeling; C Hallstrom; C Katona; D King; B Leonard; S Levine; A Phanjoo; M Peet; C Thompson Journal: J Psychopharmacol Date: 1993-01 Impact factor: 4.153
Authors: G R Twitchell; G L Hanna; E H Cook; S F Stoltenberg; H E Fitzgerald And; R A Zucker Journal: Alcohol Clin Exp Res Date: 2001-07 Impact factor: 3.455
Authors: Nassima Ait-Daoud; John D Roache; Michael A Dawes; Lei Liu; Xin-Qun Wang; Martin A Javors; Chamindi Seneviratne; Bankole A Johnson Journal: Alcohol Clin Exp Res Date: 2009-05-04 Impact factor: 3.455
Authors: Rachel D Thompson; Jaimee L Heffner; Judith A Strong; Thomas J Blom; Robert M Anthenelli Journal: Alcohol Date: 2010-07-03 Impact factor: 2.405
Authors: Henry R Kranzler; Stephen Armeli; Howard Tennen; Jonathan Covault; Richard Feinn; Albert J Arias; Helen Pettinati; Cheryl Oncken Journal: J Clin Psychopharmacol Date: 2011-02 Impact factor: 3.153
Authors: Amy R Furay; John F Neumaier; Andrew T Mullenix; Karl K Kaiyala; Nolan K Sandygren; Blair J Hoplight Journal: Alcohol Date: 2010-09-16 Impact factor: 2.405
Authors: Jonathan P Roiser; Jamey Levy; Stephen J Fromm; David Goldman; Colin A Hodgkinson; Gregor Hasler; Barbara J Sahakian; Wayne C Drevets Journal: J Psychopharmacol Date: 2012-04-10 Impact factor: 4.153
Authors: Frances R Levin; Adam Bisaga; Wilfrid Raby; Efrat Aharonovich; Eric Rubin; John Mariani; Daniel J Brooks; Fatima Garawi; Edward V Nunes Journal: J Subst Abuse Treat Date: 2007-06-15
Authors: Stephen Armeli; Tamlin S Conner; Jonathan Covault; Howard Tennen; Henry R Kranzler Journal: J Stud Alcohol Drugs Date: 2008-11 Impact factor: 2.582
Authors: Brian Hitsman; Bonnie Spring; Regina Pingitore; Marcus Munafò; Donald Hedeker Journal: Psychopharmacology (Berl) Date: 2007-02-14 Impact factor: 4.415